龙宇医药 (837836.oc)

+ 收藏

财务摘要(报告期)(龙宇医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) -0.08-0.200.01-0.050.11
 每股收益 - 稀释(元) -0.08-0.200.01-0.050.10
 每股收益 - 期末股本摊薄(元) -0.08-0.20--0.060.11
 每股净资产BPS(元) 2.392.462.662.622.78
 每股经营活动产生的现金流量净额(元) 0.02-0.120.180.640.58
 每股营业收入(元) 0.631.570.862.050.93
关键比率:
 净资产收益率 - 摊薄(%) -3.17-7.920.03-2.204.03
 净资产收益率 - 加权(%) -3.12-7.740.42-2.003.88
 净资产收益率 - 平均(%) -3.12-7.680.03-1.993.77
 净资产收益率 - 扣除(%) -4.59-6.430.05-0.513.66
 总资产净利率 - 平均(%) -2.03-5.040.34-2.412.57
 总资产报酬率ROA(%) -2.20-3.561.050.683.31
 投入资本回报率ROIC(%) -2.18-5.680.51-2.553.17
 销售毛利率(%) 31.7038.1836.7542.2841.58
 销售净利率(%) -10.42-11.281.42-4.6011.37
 资产负债率(%) 20.6324.3923.0824.1726.09
 资产周转率(倍) 0.190.450.240.520.23
 销售商品提供劳务收到的现金/营业收入(%) 114.48118.78119.68132.71155.64
 营业利润同比增长率(%) -351.71-757.08-69.41-96.04-18.64
 营业收入同比增长率(%) -26.53-23.34-7.31-22.07-34.86
 利润总额同比增长率(%) -321.63-812.78-73.61-96.07-11.30
 归属母公司股东的净利润同比增长率(%) -10,732.21-238.56-99.36-115.03-24.63
 扣非后归属母公司股东的净利润同比增长率(%) -8,930.06-1,097.31-98.78-103.80-30.63
 总资产同比增长率(%) -12.28-7.15-11.62-12.96-8.52
 总负债同比增长率(%) -21.61-6.31-21.8210.26-4.18
 净资产同比增长率(%) -10.21-5.95-4.44-17.40-10.13
利润表摘要:
 营业总收入(元) 28,342,636.9370,105,189.9138,575,053.7091,446,863.3841,618,841.58
 营业总成本(元) 30,845,850.1575,022,111.9835,550,115.1681,708,908.3432,937,053.49
 营业收入(元) 28,342,636.9370,105,189.9138,575,053.7091,446,863.3841,618,841.58
 营业利润(元) -4,067,111.66-5,563,870.431,615,769.34846,752.205,282,640.94
 利润总额(元) -3,428,552.25-5,971,822.341,546,950.14837,816.325,861,120.68
 净利润(元) -2,952,922.46-7,909,574.36548,546.05-4,210,501.274,732,140.95
 归属母公司股东的净利润(元) -3,383,036.26-8,720,033.5431,818.75-2,575,621.865,008,947.00
 非经常性损益(元) 1,508,162.63-1,642,520.67-23,573.86-1,984,503.86458,059.63
 归属母公司股东的净利润扣除非经常性损益(元) -4,891,198.89-7,077,512.8755,392.61-591,118.004,550,887.37
资产负债表摘要:
 流动资产(元) 106,247,325.10117,006,785.04124,221,754.30127,112,155.52135,514,385.22
 固定资产(元) 19,204,098.1920,187,204.8525,423,862.3126,643,289.1829,215,044.60
 长期股权投资(元) 274,133.72269,686.41235,876.8997,051.25723,408.06
 资产总计(元) 140,187,889.34151,064,443.52159,809,129.93162,697,185.46180,813,034.99
 流动负债(元) 28,217,159.8436,102,412.1736,110,241.5838,508,463.7846,251,243.28
 非流动负债(元) 699,042.87737,422.26775,801.64814,181.02929,630.13
 负债合计(元) 28,916,202.7136,839,834.4336,886,043.2239,322,644.8047,180,873.41
 股东权益(元) 111,271,686.63114,224,609.09122,923,086.71123,374,540.66133,632,161.58
 归属母公司股东的权益(元) 106,669,177.26110,052,213.52118,794,423.02117,018,646.91124,313,276.91
 资本公积(元) 17,305,246.2717,305,246.2717,305,246.2715,561,288.9115,273,585.85
 盈余公积(元) 8,454,120.138,454,120.137,981,868.087,981,868.086,758,457.92
 未分配利润(元) 36,193,810.8639,576,847.1248,791,308.6748,759,489.9257,565,233.14
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 32,445,684.3183,269,970.4146,167,595.15121,356,972.1364,776,952.69
 经营活动产生的现金净流量(元) 953,262.73-5,542,231.268,172,570.7728,830,862.0726,048,195.27
 购建固定无形长期资产支付的现金(元) 32,010.00200,000.00200,000.00810,383.09477,776.37
 投资支付的现金(元) 29,700,000.0051,480,000.0030,450,000.00115,000,000.00-
 投资活动产生的现金净流量(元) -3,960,943.594,306,993.52-1,772,020.91-5,724,179.7913,149,916.00
 取得借款收到的现金(元) 10,218,080.0014,360,000.0012,000,000.0015,500,000.003,500,000.00
 筹资活动产生的现金净流量(元) -2,737,441.94-1,425,591.50-1,777,856.93-23,903,059.94-23,635,998.98
 现金及现金等价物净增加(元) -5,745,122.80-2,660,829.244,622,692.93-796,377.6615,562,112.29
 期末现金及现金等价物余额(元) 2,965,644.428,710,767.2216,238,189.3911,371,596.4627,730,086.41
 折旧与摊销(元) 1,373,879.272,740,943.081,277,930.372,946,935.731,608,500.97
公告日期 2024-08-262024-04-302023-08-252023-04-282022-08-23
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院